A post hoc pooled analysis to evaluate hypoglycaemia risk with insulin glargine 300 U/mL (Gla ‐300) versus 100 U/mL (Gla‐100) over wider nocturnal windows in people with type 2 diabetes on a basal‐only insulin regimen
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - August 30, 2018 Category: Endocrinology Authors: Geremia B. Bolli MD , Carol Wysham MD , Miles Fisher MD , Soazig Chevalier MS , Anna MG Cali MD , Bruno Leroy MD , Matthew C. Riddle MD Source Type: research

Association of Abdominal Muscle Composition with Prediabetes and Diabetes: The CARDIA Study
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - August 30, 2018 Category: Endocrinology Authors: Andrea Granados MD , Achamyeleh Gebremariam MS , Samuel S. Gidding MD , James G. Terry MS , J. Jeffrey Carr MD, MSc , Lyn M. Steffen PhD,MPH, RD , David R. Jacobs Jr, PhD , Joyce M. Lee MD, MPH Source Type: research

Intensive multidisciplinary weight management in patients with type 1 diabetes and obesity: A one ‐year retrospective matched cohort study
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - August 30, 2018 Category: Endocrinology Authors: Adham Mottalib MD , Shaheen Tomah MD , Samar Hafida MD , Taha Elseaidy BS , Megan Kasetty BS , Sahar Ashrafzadeh AB , Osama Hamdy MD Source Type: research

Glycaemic control and hypoglycaemia benefits with insulin glargine 300 U/mL extend to people with type 2 diabetes and mild ‐to‐moderate renal impairment
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - August 30, 2018 Category: Endocrinology Authors: F. Javier Escalada MD , Serge Halimi MD , Peter A. Senior PhD , Mireille Bonnemaire MD , Anna M. G. Cali MD , Lydie Melas ‐Melt MSc , Janaka Karalliedde PhD , Robert A. Ritzel MD Source Type: research

Mechanistic Insights From Sequential Combination Therapy With An SGLT2 Inhibitor and DPP ‐IV Inhibitor: Results From the CANARIS Trial using Canagliflozin and Teneligliptin
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - August 27, 2018 Category: Endocrinology Authors: Sumie Okahata MD, PhD , Kentaro Sakamoto MD, PhD , Takako Mitsumatsu MD, PhD , Yuko Kondo MD , Shoji Tanaka MD , Teruo Shiba MD Source Type: research

Changes in Arginine are Inversely Associated with Type 2 Diabetes: A Case ‐Cohort Study in the PREDIMED Trial
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - August 27, 2018 Category: Endocrinology Authors: Edward Yu , Miguel Ruiz ‐Canela , Cristina Razquin , Marta Guasch‐Ferre , Estefania Toledo , Dong D. Wang , Christopher Papandreou , Courtney Dennis , Clary Clish , Liming Liang , Monica Bullo , Dolores Co Source Type: research

Atrial fibrillation and type 2 diabetes: prevalence, etiology, pathophysiology and effect of anti ‐diabetic therapies
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - August 25, 2018 Category: Endocrinology Authors: David S. H. Bell MB , Edison Goncalves MD Source Type: research

Meta ‐analysis of the association between sodium‐glucose co‐transporter‐2 inhibitors and risk of skin cancer among patients with type 2 diabetes
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - August 24, 2018 Category: Endocrinology Authors: Huilin Tang MSc , Keming Yang MD , Yiqing Song MD , Jiali Han PhD Source Type: research

Impact on HbA1c and body weight of switching from other GLP ‐1 receptor agonists to semaglutide: A model‐based approach
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - August 24, 2018 Category: Endocrinology Authors: Rune V. Overgaard PhD , S øren Ø. Lindberg MD , Desirée Thielke MD Source Type: research

Real ‐World Opportunity of Empagliflozin to Improve Blood Pressure Control in African Americans with Type 2 Diabetes: An NCDR® “Research‐to‐Practice” Project From the Diabetes Collaborative Registry (DCR)
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - August 23, 2018 Category: Endocrinology Authors: Suzanne V. Arnold MD MHA , Leo Seman MD PhD , Fengming Tang MS , Poghni A. Peri ‐okonny MD , Keith C. Ferdinand MD , Sanjeev N. Mehta MD MPH , Abhinav Goyal MD MHS , Laurence S. Sperling MD , Mikhail Kosiborod MD Source Type: research

Comment on Ryan, et al. Comparative effectiveness of canagliflozin, SGLT2 inhibitors and non ‐SGLT2 inhibitors on the risk of hospitalization for heart failure and amputation in patients with type 2 diabetes mellitus: A real‐world meta‐analysis of 4 observational databases (OBSERVE‐4D). Diabetes Obes Metab. 2018; doi: 10.1111/dom.13424.
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - August 23, 2018 Category: Endocrinology Authors: Patrick B. Ryan , Norm Rosenthal Source Type: research

Management of patients with diabetes and heart failure with reduced ejection fraction: an international comparison
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - August 23, 2018 Category: Endocrinology Authors: Suzanne V. Arnold MD MHA , Jonathan Yap MD , Carolyn S.P. Lam MBBS PhD , Fengming Tang MS , Wan T. Tay PhD , Tiew H.K. Teng PhD , Darren K. McGuire MD MHSc , James L. Januzzi MD , Gregg C. Fonarow MD , Frederick A. Mas Source Type: research

Effectiveness of dapagliflozin versus comparators on renal endpoints in the real world. A multicentre retrospective study
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - August 23, 2018 Category: Endocrinology Authors: Gian Paolo Fadini , Anna Solini , Maria Laura Manca , Giuseppe Penno , Adriano Gatti , Roberto Anichini , Stefano Del Prato , Angelo Avogaro , Source Type: research

Genetic Polymorphisms of the Endocannabinoid System in Obesity and Diabetes
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - August 21, 2018 Category: Endocrinology Authors: Joe Doris , Sophie A. Millar , Iskandar Idris , Saoirse E. O'Sullivan Source Type: research

Efficacy and Safety of Once ‐weekly Dulaglutide Versus Insulin Glargine in Mainly Asian Patients with Type 2 Diabetes Mellitus on Metformin and/or a Sulfonylurea: a 52‐week Open‐label, Randomized Phase 3 Trial
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - August 21, 2018 Category: Endocrinology Authors: Weiqing Wang MD , Luis Nevarez Ruiz MD , Ekaterina Filippova MD , Ki Ho Song MD , Bei Tao MD , Liqun Gu MD , Feng Wang MD , Pengfei Li PhD , Jun Yang MD Source Type: research